Remove tag frontiers-health
article thumbnail

Grand Rounds April 7, 2023: A Nudge Towards Cardiovascular Health: Incorporating Insights From Behavioral Science to Improve Cardiovascular Care Delivery (Srinath Adusumalli, MD, MSHP, MBMI, FACC)

Rethinking Clinical Trials

Nudges and other behavioral interventions are prevalent in industries like business and entertainment, but there is an opportunity for nudges in medicine and health care delivery. Launched in 2016, the Penn Medicine Nudge Unit is the world’s first behavioral design team embedded within a health system.

Medicine 100
article thumbnail

Bluebird’s $2.8M Gene Therapy Zynteglo Wins Landmark FDA Approval for Beta Thalassemia

XTalks

But bluebird bio has said such setbacks are expected for a company at the frontier of developing gene therapies for rare diseases. Zynteglo’s hefty price tag of $2.8 The road to Zynteglo’s approval was a bit rocky and included an FDA delay (the most recent in June) over production test concerns.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Simone Oostindie, PhD, Director, Research and Discovery, Gyes, on: ‘Avidity engineering: A next frontier in the development of differentiating antibody therapeutics’. These include: Chairperson Keyt on: ‘IgM antibodies as receptor cross-linking agents for DR-5 and other TNF targets’.